BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18349139)

  • 1. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
    Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
    PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.
    Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ
    J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.
    Morimoto S; Lu QW; Harada K; Takahashi-Yanaga F; Minakami R; Ohta M; Sasaguri T; Ohtsuki I
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):913-8. PubMed ID: 11773635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
    McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
    Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice.
    Lu D; Ma Y; Zhang W; Bao D; Dong W; Lian H; Huang L; Zhang L
    Hypertension; 2012 Jul; 60(1):81-9. PubMed ID: 22665122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin.
    Chang AN; Harada K; Ackerman MJ; Potter JD
    J Biol Chem; 2005 Oct; 280(40):34343-9. PubMed ID: 16043485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
    Robinson P; Mirza M; Knott A; Abdulrazzak H; Willott R; Marston S; Watkins H; Redwood C
    J Biol Chem; 2002 Oct; 277(43):40710-6. PubMed ID: 12186860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
    Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
    Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
    PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy-causing deletion K210 in cardiac troponin T alters phosphorylation propensity of sarcomeric proteins.
    Sfichi-Duke L; Garcia-Cazarin ML; Sumandea CA; Sievert GA; Balke CW; Zhan DY; Morimoto S; Sumandea MP
    J Mol Cell Cardiol; 2010 May; 48(5):934-42. PubMed ID: 20079745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation.
    Chen Y; Zhang Z; Hu F; Yang W; Yuan J; Cui J; Hao S; Hu J; Zhou Y; Qiao S
    J Steroid Biochem Mol Biol; 2015 Mar; 147():92-102. PubMed ID: 25541436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.